The one-year returns have been notable for Ocular Therapeutix (NASDAQ:OCUL) shareholders despite underlying losses increasing

Passive investing in index funds can match the market, but picking high-performing stocks like Ocular Therapeutix (OCUL) can boost returns. Despite a recent rise, it's important to assess factors like revenue growth, profitability, and balance sheet strength for long-term investment decisions.